MTX652
Asset
Inhibits USP30 to promote mitophagy.
- Stage
- Phase 2
- Modality
- Small molecule
- Target
- Autophagy
- 2
- Indications
- 0
- Trials
- 2
- Developers
Indications
2Acute kidney injury
Phase 2, missiontherapeutics.com, 10 Oct 2026
Heart Failure/HFpEF
Phase 2, missiontherapeutics.com, 10 Oct 2026
In the full profile
- Targets and what it contains2
- Owner and partners2
- Evidence for its targets2
- Competitors2
- Aging relevance2
Every asset’s record: target, stage, trials and the evidence behind it.